1. Fatal disseminated Anncaliia algerae myositis mimicking polymyositis in an immunocompromised patient
- Author
-
Clinton Turner, Graham Chiu, Linda Graham, Thomas Robertson, David Wang, Damien Stark, Richard Newbury, Fouzia Ziad, Justin Copeland, and Matthew R Watts
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.disease ,Polymyositis ,03 medical and health sciences ,Psoriatic arthritis ,030104 developmental biology ,0302 clinical medicine ,Neurology ,Anncaliia algerae ,Intensive care ,Pediatrics, Perinatology and Child Health ,Biopsy ,medicine ,Disseminated disease ,Neurology (clinical) ,Respiratory system ,business ,030217 neurology & neurosurgery ,Genetics (clinical) ,Myositis - Abstract
We report the first New Zealand case of Anncaliia algerae myositis in a 55-year-old man with a history of psoriatic arthritis, treated with long-term immunosuppressive therapy. He resided in the city of Rotorua, which is famous for geothermal hot springs. A vastus lateralis muscle biopsy was performed to investigate the cause of an unexplained myositis. Light microscopy demonstrated a necrotizing myositis with scattered clusters of ovoid spores within the myocyte cytoplasm resembling microsporidia. DNA analysis by PCR and electron microscopy confirmed microsporidial myositis with features characteristic of A. algerae. Immunosuppressive drugs were stopped and the patient was treated with cholestyramine wash and albendazole. The patient deteriorated with involvement of bulbar and respiratory muscles requiring intensive care and ventilation. He died 3 weeks after diagnosis. Post-mortem examination of skeletal muscle from tongue and intercostal muscles also revealed numerous organisms confirming disseminated disease.
- Published
- 2021
- Full Text
- View/download PDF